MIBG is a norepinephrine analog that, when radiolabeled with I-131, provides selective radiation therapy via uptake by the human norepinephrine transporter (hNET), which is widely expressed on the neuroblastoma cell surface [3]. The gene discussed is SLC6A2; the disease is neuroblastoma.